Healthcare Industry News: ultrasound
News Release - November 26, 2012
Toshiba’s New MR Series Offers Technology Investment for the FutureFull Upgrade Path Available with Vantage Titan 1.5T Series
CHICAGO--(Healthcare Sales & Marketing Network)--RSNA Booth #3438, South Hall - Providing hospitals with MR technology that fulfills their financial needs and grows with their clinical needs, Toshiba America Medical Systems, Inc. will showcase the scalable Vantage Titan™ 1.5T MR series, which includes 8-, 16- and 32-channel MR systems, at this year’s Radiological Society of North America (RSNA) annual meeting in Chicago, Nov. 25 – 30, 2012 (Booth #3438, South Hall).
Vantage Titan 8-channel is an ideal MR for the majority of clinical applications, offering patient-friendly features including a 71 cm bore, Toshiba’s exclusive Pianissimo™ noise-reduction technology, advanced non-contrast imaging, integrated coils with Octave SPEEDER™ technology and an intuitive M-Power user interface.
For customers who require enhanced cardiac imaging, the Vantage Titan line is easily upgradeable to a 32-channel system, enabling higher spatial and temporal resolution for better images of moving anatomy. The line is also enhanced with a modern, sleek exterior, including new covers and soft, patient-soothing lighting around the bore.
To improve orthopedic and body image quality, the entire series is available with 16 channel Flex SPEEDER coils that conform more closely to the anatomy, greatly improving signal-to-noise ratio. The coils are available in two different sizes and can be used for orthopedic, abdominal and general-purpose imaging of adults, and head, neck and spine imaging of pediatrics. For pediatrics, where standard coils are not optimal, the flexible coils can conform to nearly any body part and provide excellent image quality.
“With the Vantage Titan series, hospitals can invest in an 8-channel MR system today, with the option to upgrade if their clinical needs change in the future,” said Stuart Clarkson, director, MR Business Unit, Toshiba. “The patient-friendly features make exams more comfortable for patients, enabling hospitals to increase throughput and reduce retakes.”
About Toshiba America Medical Systems, Inc.
With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com.
About Toshiba Medical Systems Corporation
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba.
Toshiba is a world-leading diversified manufacturer, solutions provider and marketer of advanced electronic and electrical products and systems. Toshiba Group brings innovation and imagination to a wide range of businesses: digital products, including LCD TVs, notebook PCs, retail solutions and MFPs; electronic devices, including semiconductors, storage products and materials; industrial and social infrastructure systems, including power generation systems, smart community solutions, medical systems and escalators & elevators; and home appliances.
Toshiba was founded in 1875, and today operates a global network of more than 550 consolidated companies, with 202,000 employees worldwide and annual sales surpassing 6.1 trillion yen (US$74 billion). Visit Toshiba’s website at www.toshiba.co.jp/index.htm.
Vantage Titan, Octave SPEEDER and Pianissimo are trademarks of Toshiba Medical Systems Corporation.
Source: Toshiba America Medical Systems
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.